Farabi Pharmaceutical (XTEH:DFRB1) Gross Margin %: 0.00% (As of . 20)


What is Farabi Pharmaceutical Gross Margin %?

Farabi Pharmaceutical XTEH:DFRB1 Gross Margin % is 0.00% as of . 20.

Gross Margin % is calculated as gross profit divided by its revenue. Farabi Pharmaceutical's Gross Profit for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Therefore, Farabi Pharmaceutical's Gross Margin % for the quarter that ended in . 20 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Farabi Pharmaceutical's Gross Margin % or its related term are showing as below:


XTEH:DFRB1's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54
* Ranked among companies with meaningful Gross Margin % only.

Farabi Pharmaceutical had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Farabi Pharmaceutical was 0.00% per year.

Farabi Pharmaceutical  (XTEH:DFRB1) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Farabi Pharmaceutical had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Farabi Pharmaceutical Gross Margin % Related Terms

Farabi Pharmaceutical Gross Margin % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Gross Margin % Chart

Farabi Pharmaceutical Annual Data
Trend
Gross Margin %

Farabi Pharmaceutical Quarterly Data
Gross Margin %

XTEH:DFRB1 vs IMNPQ, INNV: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Gross Margin % falls into.


Farabi Pharmaceutical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Farabi Pharmaceutical's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )=Gross Profit (A: . 20 ) / Revenue (A: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

Farabi Pharmaceutical's Gross Margin for the quarter that ended in . 20 is calculated as


Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Gross Margin % of 0.00% as of . 20. Gross margin is the ratio of total gross profit to net sales. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Gross Margin % too high?
Farabi Pharmaceutical's current Gross Margin % is 0.00%.
How does Farabi Pharmaceutical's Gross Margin % compare to IMNPQ and INNV?
Farabi Pharmaceutical's Gross Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Gross Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.